Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.55 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.55 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30259923 | 0.90 | MTNR1A (0.61) | MTNR1AMTNR1BKMT2A | |
| SCHEMBL7598872 | 0.90 | L3MBTL1 (0.74) | L3MBTL1HPGDGAAMTNR1AMTNR1B | |
| SCHEMBL3919664 | 0.85 | TRPV1 (0.71) | L3MBTL1HPGDGAAMTNR1AMTNR1B | |
| SCHEMBL25139566 | 0.84 | L3MBTL1 (0.66) | L3MBTL1HPGDGAAMTNR1AMTNR1B | |
| SCHEMBL31035861 | 0.84 | TRPV1 (0.73) | L3MBTL1HPGDGAARECQLKMT2A | |
| SCHEMBL31035980 | 0.84 | TRPV1 (0.73) | L3MBTL1HPGDGAARECQLKMT2A | |
| SCHEMBL31036003 | 0.84 | TRPV1 (0.73) | L3MBTL1HPGDGAARECQLKMT2A | |
| SCHEMBL413313 | 0.81 | L3MBTL1 (0.56) | L3MBTL1HPGDGAAHDAC2CYP2C9 | |
| SCHEMBL13652538 | 0.80 | LMNA (0.70) | L3MBTL1GAAHDAC2CYP2C19CYP3A4 | |
| SCHEMBL154367 | 0.80 | MTNR1A (0.73) | L3MBTL1HPGDMTNR1AMTNR1BHDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120022024-A1 | ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022024-A1 | ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS | CUTA, MMP8, CLPP | L3MBTL1 897/4885HPGD 3631/4885GAA 1378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.